| Literature DB >> 30850653 |
Basanta Kumar Das1,2, Pragyan Roy3, Ajaya Kumar Rout4, Deepak Ranjan Sahoo3, Soumya Prasad Panda3, Sushmita Pattanaik3, Budheswar Dehury5,6, Bijay Kumar Behera4, Sudhansu Sekhar Mishra3.
Abstract
The myxovirus resistance (Mx) proteins belong to interferon-induced dynaminEntities:
Mesh:
Substances:
Year: 2019 PMID: 30850653 PMCID: PMC6408538 DOI: 10.1038/s41598-019-40323-0
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1The evolutionary history of Mx_Lr Protein was inferred using Neighbor-Joining method. The optimal tree with the sum of branch length = 5.19236111 is shown. The percentage of replicate trees in which the associated taxa clustered together in the bootstrap test (1000 replicates) was displayed. The evolutionary distances were computed using the Day-Hoff matrix based method and are in the units of the number of amino acid substitutions per site. The analysis involved 50 amino acid sequences. There were a total of 558 positions in the final dataset. Evolutionary analyses were conducted in MEGAv7.0 software Package.
Figure 2(A) Ramachandran plot of the modeled GTPase domain of Mx protein from Labeo rohita. The Plot was generated by PROCHECK Program. (B) Three-Dimensional architecture of GTPase domain of Mx protein. The protein has been displayed as solid ribbon representation with α-helices, β-sheets and turns.
Model validation report of GTPase domain of Mx_Labeo rohita.
| Model Validation Tools | Model validation parameters | Scores (%) |
|---|---|---|
| PROCHECK | Most favored region (%) | 94.7 |
| Additional allowed region (%) | 4.1 | |
| Generously allowed region (%) | 0.4 | |
| Disallowed region (%) | 0.8 | |
| Overall G-factor | −0.04 | |
| Verify 3D | Averaged 3D-1D Score > 0.2 | 97.81 |
| ERRAT | Overall Quality (%) | 79.69 |
| ProSA | Z-Score | −8.7 |
| ProQ | LG score | 5.549 |
| Max Sub | 0.539 | |
| MolProbity | Cβ deviations > 0.25 Å | 0 |
| Residues with bad bonds | 0 | |
| Residues with bad angles | 0.1 | |
| METAMQAPII | GDT_TS | 45.347 |
| RMSD | 3.542 |
Figure 3Conformational stability of apo and holo (in presence of Mg + 2) conformers of GTPase domain i.e., Mx Labeo rohita-GTP (manual docked) complexes during 100 ns MD simulation. (A) Root mean square deviation (RMSD) of backbone atoms of the modeled of apo and holo conformers. (B) Radius of gyration (Rg) plot showing the compactness of trajectory of apo and holo conformers of GTPase domain. (C) Comparative analysis of the root mean square fluctuation (RMSF) for Cα atoms of Mx Labeo rohita. (D) Variation of H-bonds participated in the intermolecular interaction of GTP with modeled GTPase domain of Mx protein during 100 ns simulation. (E) Superimposition of pre‐ and post‐MD GTPase-GTP complex before and after MD simulation. (F) Interactions of GTP with the active site amino acids of GTPase domain of Mx protein from Labeo rohita shown in PyMOL (in presence of Mg + 2 ions). The protein, ligand and hydrogen bonds are shown as cartoon, stick and dotted lines, respectively.
Figure 4Principal component analysis (PCA) of apo and holo conformers GTPase domain of Mx protein from Labeo rohita PCA was performed using gmx covar and gmx anaeig utility toolkits of GROMACS. (A) The eigenvalues plotted against the corresponding eigenvector indices obtained from the Cα covariance matrix constructed from the 100 ns MD trajectory. (B) Projection of the motion of the structures of the backbone atoms (apo and holo forms) of Mx_Lr in phase space along the first two principal eigenvectors (EV1 and EV2). (C) The superimposition of structural coordinates associated with the principal component 1 (PC1) of apo conformers displaying the global motion. The superimposition of structural coordinates associated with the principal component 1 (PC1) of holo conformers of GTPase domain displaying the global motion. The initial conformations in blue, the final in red and the intermediate ones were displayed in silver.
Figure 5Secondary structure evolution and porcupine plot analysis of apo and holo conformers of GTPase domain. (A) Secondary structure components of both Mx_Lr and Mx_Lr-GTP during the course of 100 ns simulation time (the colour segments provided just below the figure represents the secondary structure properties); (B) The Porcupine plot of the first eigenvector generated through principal component analysis of the representative structures of GTPase domain and GTPase-GTP complexes. The vectors, represented as arrows, show the tendency of movement.
MM/PBSA binding free energy of GTP with GTPase domain Mx protein from Rohu.
| Energetic terms | van der Waal energy | Electrostatic energy | Polar solvation energy | SASA energy | Binding energy |
|---|---|---|---|---|---|
| Energy (kJ/mol) | −246.207 ± 0.596 | −1076.413 ± 2.704 | 1343.902 ± 2.576 | −20.881 ± 0.027 | −153.371 ± 1.784 |
The energetic terms were derived using 500 snapshots from the equilibrated portion of trajectory (70–100 ns).
Figure 6(A–D) Expression of β-actin and Mx transcripts in (A) Kidney (B) Liver (C) Muscle (D) Spleen after Semi-quantitative PCR. (A) Kidney M: Marker; Lane 2; β-actin, Lane 3: Mx (1 day); Lane 4: β-actin, Lane 5: Mx (2 days); Lane 6: β-actin, Lane 7: Mx (3 days); Lane 8: β-actin, Lane 9: Mx (4 days); Lane 10: β-actin, Lane 11: Mx (5 days); Lane 12: β- actin, Lane 13: Mx (7 days); Lane 14: β-actin, Lane 15/17: Mx (14 days). (B) Liver M: Marker; Lane1: β-actin, Lane 2: Mx (1 day); Lane 3: β-actin, Lane 4: Mx (2 days); Lane 5: β-actin, Lane 6: Mx (3 days); Lane 7: β-actin, Lane 8: Mx (4 days); Lane 9: β-actin, Lane 10: Mx (5 days); Lane 11: β-actin, Lane 12: Mx (7 days); Lane13: β-actin, Lane 14: Mx (8 days); Lane 15/17: β-actin, Lane 16: Mx (14 days). (C) Muscle M: Marker; Lane 2; β-actin, Lane 3: Mx (1 day); Lane 4: β-actin, Lane 5: Mx (2 days); Lane 6: β-actin, Lane 7: Mx (3 days); Lane 8: β-actin, Lane 9: Mx (4 days); Lane 10: β-actin, Lane 11: Mx (5 days); Lane 12: β-actin, Lane 13: Mx (7 days); Lane 14: β-actin, Lane 15: Mx (14 days). (D) Spleen M: Marker; Lane1: β-actin, Lane 2: Mx (1 day); Lane 3: β-actin, Lane 4: Mx (2 days); Lane 5: β-actin, Lane 6: Mx (3 days); Lane 7: β-actin, Lane 8: Mx (4 days); Lane 9: β-actin, Lane 10: Mx (5 days); Lane 11: β-actin, Lane 12: Mx (7 days); Lane13/15: β-actin, Lane 14/16: Mx (14 days).
Figure 7Expression of Mx in (A) Kidney, (B) Spleen, (C) Liver and (D) Muscle after Poly I:C stimulation. The relative expression of Mx gene was normalized to the expression of β-actin (internal control) and expressed as fold changes relative to the untreated control group. The mean value of four fish (n = 4) is shown and the bars indicate standard error.
Figure 8(A) Expression of Mx protein in spleen tissue during the 14 day experimental period. The blue arrow shows the expression of 72 kDa Mx protein. (L-1 spleen treated 1 Day, L-2 spleen treated 2 Day, L-3 spleen treated 3 Day, L-4 spleen treated 4 Day, L-5 spleen treated 5 Day, L-6 marker, L-7 spleen treated 7 Day, L-8 spleen treated 14 Day, L-9 spleen control 1 Day, L-10 spleen control 7 Days). (B) Expression of Mx protein in kidney tissue during the 14 day experimental period. The blue arrow shows the expression of 72 kDa Mx protein. (L-1 kidney treated 1 Day, L-2 kidney treated 2 Day, L-3 kidney treated 3 Day, L-4 kidney treated 4 Day, L-5 kidney treated 5 Day, L-6 marker, L-7 kidney treated 7 Day, L-8 kidney treated 14 Day, L-9 kidney control 1 Day, L-10 kidney control 14 Days).
Primer used in PCR reaction (F = Forward primer and R = Reverse primer).
| Primer | 5′-Primer seq | Target gene |
|---|---|---|
| 2F241–261Mx | CGCTGCCTAGGGGAACAGGT | MxcDNA |
| 3R713–734Mx | CCTTTGTCCACCAAGTCCGGT | MxcDNA |
| 3F592–613Mx | GACAAGAAACCATCAGCTTGG | MxcDNA |
| 4R1048–1068Mx | AGTAGGAACTCCAGCTCCCA | MxcDNA |
| 4F1034–1055Mx | GGATCTTAGAGCACTGGGAGC | MxcDNA |
| 5R1591–1612Mx | GCTGTAGAGACGGTCTTGGGA | MxcDNA |
| 5F1598–1619Mx | ACCGTCTCTACAGCAGTCAGC | MxcDNA |
| 6R1807–1828Mx | TCCAATCATGGCAAGCATTGC | MxcDNA |
| qPCR 6F1762–1784Mx | GTCCAGTACCACATGCTGGACC | MxcDNA |
| qPCR 7R1905–1927Mx | TTTGCCAGCACTCCTCAGGCGT | MxcDNA |
| Forward primer | TTCGAGCAGGAGATGGGCACTG | β-actin |
| Reverse primer | GCATCCTGTCAGCAATGCCA | β-actin |
| 3′Gene Racer Primer | GCTGTCAACGATACGCTACGTAACG | |
| 3′Gene Nested Primer | CGCTACGTAACGGCATGACAGTG | |
| 5′Gene Racer Primer | GCACGAGGACACUGACAUGGACUGA | |
| 5′Gene Nested Primer | GGACACTGACATGGACTGAAGGAGTA |